SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-08-035829
Filing Date
2008-06-18
Accepted
2008-06-18 16:39:56
Documents
2
Period of Report
2008-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v117671_8k.htm 8-K 28899
2 v117671_ex10-1.htm EX-10.1 17785
  Complete submission text file 0001144204-08-035829.txt   48388
Mailing Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168
Business Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168 212-682-3096
Lev Pharmaceuticals Inc (Filer) CIK: 0001144062 (see all company filings)

IRS No.: 880211496 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32947 | Film No.: 08906081
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1